SBI Pharma Fund (Equity, Sectoral)

128.28
16.48%
NA
NA
Capital Appreciation
Long Term Horizon
High
2.24%
18 yrs 6 months14 Jul 1999
₹ 1053.91 Cr11 Dec 2017

Similar Funds

Franklin Build India Fund
  • Return (CAGR) 19.33%
  • Crisil Ranking 3
  • Value Research
ICICI Prudential Banking And Financial Services Fund
  • Return (CAGR) 21.34%
  • Crisil Ranking NA
  • Value Research
SBI FMCG Fund
  • Return (CAGR) 16.17%
  • Crisil Ranking NA
  • Value Research NA
RELIANCE BANKING FUND
  • Return (CAGR) 25.16%
  • Crisil Ranking NA
  • Value Research
DSP BlackRock India T.I.G.E.R. Fund
  • Return (CAGR) 18.65%
  • Crisil Ranking 3
  • Value Research
UTI-Banking Sector Fund
  • Return (CAGR) 18.17%
  • Crisil Ranking NA
  • Value Research
HDFC Infrastructure Fund
  • Return (CAGR) 8.30%
  • Crisil Ranking 5
  • Value Research
Baroda Pioneer Banking And Financial Services Fund - Plan A
  • Return (CAGR) 14.37%
  • Crisil Ranking NA
  • Value Research
Birla Sun Life Banking And Financial Services Fund
  • Return (CAGR) 29.17%
  • Crisil Ranking NA
  • Value Research

Minimum Investment

  • ₹ 5000.00 for Lumpsum

Exit Load

Investment Objective

The scheme seeks maximum growth opportunities through investments in Pharma stocks.

Scheme Documents

TenureReturns (CAGR)
1 Month
1.95
3 Month
6.86
3 YR
2.47
TenureReturns (CAGR)
1 YR
0.8
5 YR
9.04
10 YR
17.6

Portfolio

Company Name% Assets
Divi's Laboratories Ltd.11.48
Cipla Ltd.9.49
Aurobindo Pharma Ltd.8.59
Strides Shasun Ltd.7.34
Natco Pharma Ltd.5.53
Torrent Pharmaceuticals Ltd.4.73
Cadila Healthcare Ltd.4.73
Alkem Laboratories Ltd.4.56
Thyrocare Technologies Ltd.3.64
Dr. Lal Pathlabs Ltd.3.27

Top Sectoral Holdings

Sector Name% Assets
Healthcare90.22

Indicators

Portfolio turnover ratio67
Standard Deviation16.86%
Beta0.95%

Tanmaya Desai

Mr. Desai is a B.E. (Electronics), MBA (Finance) and CFA (Level III).
Prior to joining SBI Mutual Fund he has worked with D.J. Sanghvi College of Engineering and Patni Computer Systems Ltd.
© CRISIL Limited 2017. All Rights Reserved